pLKO.1 mCherry Citations (7)
Originally described in: Emory Custom Cloning Core Plasmids - Oskar LaurUnpublished
Articles Citing pLKO.1 mCherry
| Articles |
|---|
| Identification of a STIM1 Splicing Variant that Promotes Glioblastoma Growth. Xie J, Ma G, Zhou L, He L, Zhang Z, Tan P, Huang Z, Fang S, Wang T, Lee YT, Wen S, Siwko S, Wang L, Liu J, Du Y, Zhang N, Liu X, Han L, Huang Y, Wang R, Wang Y, Zhou Y, Han W. Adv Sci (Weinh). 2022 Apr;9(11):e2103940. doi: 10.1002/advs.202103940. Epub 2022 Jan 25. PubMed |
| CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism. Medler J, Kucka K, Melo V, Zhang T, von Rotenhan S, Ulrich J, Bremer E, Hudecek M, Beilhack A, Wajant H. Theranostics. 2022 Jan 1;12(4):1486-1499. doi: 10.7150/thno.66119. eCollection 2022. PubMed |
| Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression. Yoo S, Sinha A, Yang D, Altorki NK, Tandon R, Wang W, Chavez D, Lee E, Patel AS, Sato T, Kong R, Ding B, Schadt EE, Watanabe H, Massion PP, Borczuk AC, Zhu J, Powell CA. Nat Commun. 2022 Mar 24;13(1):1592. doi: 10.1038/s41467-022-29230-7. PubMed |
| The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11. Boehm D, Lam V, Schnolzer M, Ott M. Cell Rep. 2023 Mar 28;42(3):112234. doi: 10.1016/j.celrep.2023.112234. Epub 2023 Mar 9. PubMed |
| Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer. Heylen E, Verstraete P, Van Aerschot L, Geeraerts SL, Venken T, Timcheva K, Nittner D, Verbeeck J, Royaert J, Gijbels M, Uyttebroeck A, Segers H, Lambrechts D, Cools J, De Keersmaecker K, Kampen KR. Br J Cancer. 2023 May;128(10):1862-1878. doi: 10.1038/s41416-023-02216-y. Epub 2023 Mar 17. PubMed |
| Integrated analysis of cell-specific gene expression in peripheral blood using ISG15 as a marker of rejection in kidney transplantation. Zhang Z, Qin Y, Wang Y, Li S, Hu X. Front Immunol. 2023 Mar 8;14:1153940. doi: 10.3389/fimmu.2023.1153940. eCollection 2023. PubMed |
| EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells. Melo V, Nelemans LC, Vlaming M, Lourens HJ, Wiersma VR, Bilemjian V, Huls G, de Bruyn M, Bremer E. Front Immunol. 2023 Jul 20;14:1191866. doi: 10.3389/fimmu.2023.1191866. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.